NCT05760989 - TRISCEND JAPAN Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 6, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2029

Conditions

Tricuspid Valve RegurgitationHeart Valve DiseasesCardiovascular Diseases

Interventions

DEVICE

Edwards EWJ-202 Transcatheter Tricuspid Valve Replacement System

Replacement of the native tricuspid valve through a transcatheter approach

Trial Locations (8)

Kokura Memorial Hospital, Kitakyushu-shi

Tokai University Hospital, Isehara-shi

Sendai Kousei Hospital, Sendai

Osaka Keisatsu Hospital, Osaka

Osaka University Hospital, Suita

National Cerebral and Cardiovascular Center, Suita-shi

Keio University Hospital, Shinjuku-Ku

Tokyo Women's Medical University Hospital, Shinjuku-Ku